Eosinophils as a Novel Cell Source of Prostaglandin D2: Autocrine Role in Allergic Inflammation
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
PGD(2) is a key mediator of allergic inflammatory diseases that is mainly synthesized by mast cells, which constitutively express high levels of the terminal enzyme involved in PGD(2) synthesis, the hematopoietic PGD synthase (H-PGDS). In this study, we investigated whether eosinophils are also able to synthesize, and therefore, supply biologically active PGD(2). PGD(2) synthesis was evaluated within human blood eosinophils, in vitro differentiated mouse eosinophils, and eosinophils infiltrating inflammatory site of mouse allergic reaction. Biological function of eosinophil-derived PGD(2) was studied by employing inhibitors of synthesis and activity. Constitutive expression of H-PGDS was found within nonstimulated human circulating eosinophils. Acute stimulation of human eosinophils with A23187 (0.1-5 μM) evoked PGD(2) synthesis, which was located at the nuclear envelope and was inhibited by pretreatment with HQL-79 (10 μM), a specific H-PGDS inhibitor. Prestimulation of human eosinophils with arachidonic acid (10 μM) or human eotaxin (6 nM) also enhanced HQL-79-sensitive PGD(2) synthesis, which, by acting on membrane-expressed specific receptors (D prostanoid receptors 1 and 2), displayed an autocrine/paracrine ability to trigger leukotriene C(4) synthesis and lipid body biogenesis, hallmark events of eosinophil activation. In vitro differentiated mouse eosinophils also synthesized paracrine/autocrine active PGD(2) in response to arachidonic acid stimulation. In vivo, at late time point of the allergic reaction, infiltrating eosinophils found at the inflammatory site appeared as an auxiliary PGD(2)-synthesizing cell population. Our findings reveal that eosinophils are indeed able to synthesize and secrete PGD(2), hence representing during allergic inflammation an extra cell source of PGD(2), which functions as an autocrine signal for eosinophil activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, PGD2 is also produced and released by other cell types.”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [65]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PPARα–leukotriene B4 pathway to inflammation control
Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W. (1996) · Nature · doi:10.1038/384039a0 · Cited by 1,345
Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K., Nakamura, M., Takano, S., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.255 · Cited by 1,099
Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE.
Lewis, R. A., Soter, N. A., Diamond, P. T., Austen, K. F., Oates, J. A., & Roberts, L. J. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.4.1627 · Cited by 584
Mediator Release after Nasal Airway Challenge with Allergen
Naclerio, R. M., Creticos, P. S., Norman, P. S., & Lichtenstein, L. M. (1986) · American Review of Respiratory Disease · doi:10.1164/arrd.1986.134.5.1102 · Cited by 562
Release of Prostaglandin D2into Human Airways during Acute Antigen Challenge
Murray, J. J., Tonnel, A. B., Brash, A. R., Roberts, L. J., Gosset, P., Workman, R., Capron, A., & Oates, J. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198609253151304 · Cited by 469
Molecular Cloning and Characterization of the Human Prostanoid DP Receptor
Boie, Y., Sawyer, N., Slipetz, D. M., Metters, K. M., & Abramovitz, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18910 · Cited by 336
Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor
Monneret, G., Gravel, S., Diamond, M., Rokach, J., & Powell, W. S. (2001) · Blood · doi:10.1182/blood.v98.6.1942 · Cited by 326
The Bronchoconstrictor Effect of Inhaled Prostaglandin D2 in Normal and Asthmatic Men
Hardy, C. C., Robinson, C., Tattersfield, A. E., & Holgate, S. T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407263110401 · Cited by 316
Nagata, K., Hirai, H., Tanaka, K., Ogawa, K., Aso, T., Sugamura, K., Nakamura, M., & Takano, S. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01251-x · Cited by 297
Balzar, S., Fajt, M. L., Comhair, S. A. A., Erzurum, S. C., Bleecker, E., Busse, W. W., Castro, M., Gaston, B., Israel, E., Schwartz, L. B., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201002-0295oc · Cited by 293
Cited by
The Dynamics of the Skin’s Immune System
Nguyen, A. V., & Soulika, A. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081811 · Cited by 694
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Weiler, C. R., Austen, K. F., Akin, C., Barkoff, M. S., Bernstein, J. A., Bonadonna, P., Butterfield, J. H., Carter, M., Fox, C. C., Maitland, A., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.08.023 · Cited by 123
Gülen, T., Akin, C., Bonadonna, P., Siebenhaar, F., Broesby-Olsen, S., Brockow, K., Niedoszytko, M., Nedoszytko, B., Oude Elberink, H. N. G., Butterfield, J. H., et al. (2021) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2021.06.011 · Cited by 83
Ravi, A., Butterfield, J., & Weiler, C. R. (2014) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2014.06.011 · Cited by 63
Marone, G., Galdiero, M. R., Pecoraro, A., Pucino, V., Criscuolo, G., Triassi, M., & Varricchi, G. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1555237 · Cited by 62
“PGD2 is also elaborated by activated dendritic cells (DCs) [29], macrophages [30], eosinophils [31], T helper type 2 (Th2”
BackgroundMast cell activation syndromes presenting as anaphylaxis
Akin, C. (2015) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2015.01.010 · Cited by 43
Vysniauskaite, M., Hertfelder, H.-J., Oldenburg, J., Dreßen, P., Brettner, S., Homann, J., & Molderings, G. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124912 · Cited by 30
Divekar, R., & Butterfield, J. (2015) · Allergy · doi:10.1111/all.12668 · Cited by 27
Metadata
- Authors
- Luna-Gomes, T., Magalhães, K. G., Mesquita-Santos, F. P., Bakker-Abreu, I., Samico, R. F., Molinaro, R., Calheiros, A. S., Diaz, B. L., Bozza, P. T., Weller, P. F., & Bandeira-Melo, C.
- Affiliations
- Universidade Federal do Rio de Janeiro (BR)
- Instituto Oswaldo Cruz (BR)
- Beth Israel Deaconess Medical Center (US)
- Laboratório de Inflamação, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro , Rio de Janeiro, RJ 21941-902 ,
- Corresponding author
- Weller, Peter F
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-12
- Volume
- 187
- Issue
- 12
- Pages
- 6518-6526
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3237921
- OpenAlex
- W2128382611
- Cited by
- 87
- References
- 58
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 7 · 2022: 3 · 2021: 11 · 2020: 5 · 2019: 11 · 2018: 10 · 2017: 5 · 2016: 4 · 2015: 8 · 2014: 9 · 2013: 5 · 2012: 3
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Arca - Repositório Institucional da Fiocruz (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI022571, AI020241, R37AI020241, R01AI020241, AI051645, R01AI022571, R01AI051645)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Keywords
- eosinophils, prostaglandin D2, hematopoietic prostaglandin D synthase, autocrine signaling, allergic inflammation, eosinophil activation, lipid droplets, eotaxin, arachidonic acid, prostaglandin D2 receptor, mast cells
- MeSH terms
- Animals, Catalysis, Eosinophils, Female, Hematopoiesis, Humans, Hypersensitivity, Inflammation, Intracellular Fluid, Male, Mice, Inbred BALB C, Receptors, Immunologic, Receptors, Prostaglandin, Prostaglandin D2, Intramolecular Oxidoreductases, Autocrine Communication, Paracrine Communication, Mice, Lipocalins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.